Human adipose, placenta, and umbilical cord-derived mesenchymal stem cells ameliorate imiquimod-induced psoriatic mice via reducing T cells infiltration
JIGANG LEI, ZHENYAO XU, SUKE LI, MENG LI, ZHIKAI WANG, PING LI, JING WANG, YINGLU CHEN, XIAOLE SONG, CHENGJIE REN, MEIPING SHEN, CHENGXIANG DAI
BIOCELL, Vol.45, No.3, pp. 537-546, 2021, DOI:10.32604/biocell.2021.014569
(This article belongs to the Special Issue:
Stem Cells, Protein Therapeutics, and Regenerative Medicine)
Abstract Psoriasis is an autoimmune-related chronic inflammatory disease with an approximate prevalence of 2–3%
around the world, involving increased keratinocyte proliferation. Indeed, Th17 cells and IL-17 play critical roles in the
pathogenesis of psoriasis. The monoclonal antibodies against cytokines have been shown to have effectively
immunosuppressive effects on human psoriasis. However, there are still some patients that have no response to these
treatments. Some patients have even serious side-effects which may affect their life. Mesenchymal stem cells have the
ability of immunosuppressive and anti-inflammatory effects, which may be an alternative therapy with more safety
and efficacy…
More >